An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Takeda Announces U.S. Corporate Social Responsibility (CSR) Program Aimed to Help Reduce Social Disparities
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Very Positive)
Tags
Rhea-AI Summary
Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) announced a $20 million commitment to enhance its Corporate Social Responsibility (CSR) program in the U.S. during its first year. The program focuses on health equity, climate resiliency, K-8 math literacy, and food security, partnering with 20 grant recipients who will share $16.6 million in total grants. The initiative aims to alleviate social disparities and improve overall community well-being across various sectors.
Positive
Initial commitment of $20 million to U.S. CSR program.
20 grantees selected, receiving a total of $16.6 million in grants.
Focus areas include health equity, education, climate resiliency, and food security.
Partnerships with local organizations to address community needs.
Negative
None.
− Takeda is enhancing its Corporate Social Responsibility program with significant commitment to underrepresented communities in the U.S.
− U.S. Program prioritizes health equity, climate resiliency, K-8 math literacy and food security across the country
− 20 grantees selected as FY2021 program partners
CAMBRIDGE, Mass.--(BUSINESS WIRE)--
Takeda Pharmaceutical Company Limited(TSE:4502/NYSE:TAK) (“Takeda”) today announced that it is enhancing its Corporate Social Responsibility (CSR) Program in the U.S., making an initial commitment of $20 million its first year supporting organizations in the U.S. to help improve equity among underrepresented communities in the areas of health, education, the environment and access to nutrition/food. Takeda also announced its current 2021 U.S. CSR Program grant recipients, including 20 organizations who will share $16,595,000 in total grants.
“Achieving better health outcomes requires a multi-faceted approach and a more holistic view of health and well-being,” said Ramona Sequeira, President, US Business Unit and Global Portfolio Commercialization, Takeda Pharmaceutical Company Limited. “Our philanthropic efforts in the U.S. focus on multiple areas including reducing social disparities, improving access to medicines and diagnosis, achieving environmental sustainability, promoting equitable educational opportunities and ensuring healthy food sources for vulnerable individuals and families. We’re looking forward to growing our U.S. CSR Program over the coming years and are proud to partner with organizations located in the communities where many of our employees live and work – including our U.S. hub in Massachusetts.”
Takeda’s U.S. CSR grant applications are reviewed by an internal review committee, on a rolling basis and approved through a formal governance process. Takeda partners with local and regional organizations who align with our philanthropic focus areas, share our values and our commitment to improving people’s lives for the better. Takeda’s 2021 U.S. CSR grantees include:
Promoting Food System Equity
Takeda is supporting the following organizations which are increasingfood system equity for vulnerable families in communities around the country:
Daily Table – Healthy Grocer for All Program
Food for Free – Just Eats Program
Greater Boston Food Bank – Mobile Market Program
Northern Illinois Food Bank – Mobile Market Program
The Food Project – Growing Leaders, Growing Communities Program
West End House – Family Food Program
Promoting Greater Educational Equity
Takeda’s funding of the following organizations will help advance K-8 math programs to promote greater educational equity:
City Year – Boston STEM Program
Learn Fresh – NBA Math Hoops Program
Lesley University – Culturally Relevant Math Expressions Program
STEM Next – Million Girls Moonshot Program
Tutoring Plus – After School Tutoring and Mentoring Program
Young People’s Project – Math and STEM Literacy Program
Promoting Health Equity
Takeda is supporting the following organizations with programs aimed at creating social, physical and economic environments that promote health equity for all:
Boston Healthcare for the Homeless – Horizon Family Clinic
Community Servings – Food is Medicine Program
Inner City Weightlifting – Grow and Strengthen Core Program
Health Leads – Catalyzing Hyper-Local Health Systems Transformation Program
Urban Edge – Strong Start Roxbury Program
Supporting Healthier Environments
The following organizations are receiving funding for climate resiliency initiatives building toward a healthier environment:
American Red Cross – Annual Disaster Giving Fund Program
CitySprouts – Young Leaders Program
Mystic River Watershed Association – Wicked Hot Mystic Program
Learn more about Takeda’s U.S. Corporate Social Responsibility Program and our philanthropic strategy here. For more details about Takeda’s Global CSR Program, you can find them here.
About Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited (TSE: 4502/NYSE: TAK) is a global, values-based, R&D-driven biopharmaceutical leader headquartered in Japan, committed to discover and deliver life-transforming treatments, guided by our commitment to patients, our people and the planet. Takeda focuses its R&D efforts on four therapeutic areas: Oncology, Rare Genetics and Hematology, Neuroscience, and Gastroenterology (GI). We also make targeted R&D investments in Plasma-Derived Therapies and Vaccines. We are focusing on developing highly innovative medicines that contribute to making a difference in people’s lives by advancing the frontier of new treatment options and leveraging our enhanced collaborative R&D engine and capabilities to create a robust, modality-diverse pipeline. Our employees are committed to improving quality of life for patients and to working with our partners in health care in approximately 80 countries and regions. For more information, visit https://www.takeda.com.